BridgeBio Pharma Presents Cardiac Magnetic Resonance (CMR) Imaging Evidence Consistent with Clinical Improvement Observed in the ATTRibute-CM Phase 3 Study in Patients with Transthyretin Amyloid Cardi

Rate Senwabarwana Online News?(if there is something you don't like about please feel free to contact us...your thoughts is important to us)

Total Vote: 22

100% 75% 50% 25% 10% 5% 0%

View Options